Which begs the question, how on earth can they get away with calling it a phase 1/2 trial; it is clearly only phase 1. Interestingly, Mesoblast is currently facing a class action from investors over disclosure practises.
https://www.australianclinicaltrials.gov.au/about/what-is-a-clinical-trial
Which begs the question, how on earth can they get away with...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
0.015(2.34%) |
Mkt cap ! $132.5M | |||
| Open | High | Low | Value | Volume |
| 65.0¢ | 65.5¢ | 64.0¢ | $7.759K | 11.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12290 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 51833 | 6 |
View Market Depth
| Last trade - 15.13pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.015 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 65.0¢ | 65.0¢ | 65.0¢ | 12235 | ||
| Last updated 14.48pm 06/05/2024 ? | |||||
| RCE (ASX) Chart |